Docetaxel (Taxotere) and gemcitabine (Gemzar) are active agents against breast cancer. Several phase I studies evaluated different schedules of their combination and clearly demonstrated that docetaxel and gemcitabine can
Vassilis A. Georgoulias, MD, PhD
Advertisement
Articles by Vassilis A. Georgoulias, MD, PhD
Advertisement
Latest Updated Articles
- Docetaxel/Gemcitabine: Salvage Chemotherapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer
Published: February 1st 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
This Week in Oncology: FDA Approval Shakeups and Key SITC 2025 Data
2
How Can Chlorotoxin-Directed CAR T-Cell Therapy Impact Glioblastoma Care?
3
What is the Current State of ADC Treatment in EGFR-Amplified Glioblastoma?
4
Zanidatamab-Based Regimens Exhibit Improved PFS in Gastroesophageal Cancers
5
